CoChat

Endothelial Dysfunction in Diabetes: From Mechanisms to Therapeutic Targets

Potenza, Maria, Gagliardi, Sara, Nacci, Carmela, Carratu, Maria, Montagnani, Monica · 2009 · Current Medicinal Chemistry

The DOI matches its Crossref record.

Abstract

Micro- and macrovascular complications are major causes of disability and death in patients with diabetes mellitus. Functional impairment of endothelial activity precedes the development of morphological alterations during the progression of diabetes. This endothelial dysfunction results from reduced bioavailability of the vasodilator nitric oxide (NO), mainly due to accelerated NO degradation by reactive oxygen species (ROS). Although hyperglycemia, insulin resistance, hyperinsulinemia and dyslipidemia independently contribute to endothelial dysfunction via several distinct mechanisms, increased oxidative stress seems to be the first alteration triggering several others. Mechanisms proposed to explain glucose- and lipid-induced vascular alterations in diabetes include accelerated formation of advanced glycation end-products (AGEs), protein kinase C activation, inflammatory signaling and oxidative stress. Insulin resistance with impaired PI 3-kinase effects decreases insulin mediated production of NO and reduces vasodilation, capillary recruitment and antioxidant properties of endothelium. Compensatory hyperinsulinemia enhances activation of intact MAP-kinase pathways and contributes to pro-atherogenic events by increasing secretion of endothelin-1 (ET-1), stimulating expression of adhesion molecules such as VCAM-1 and E-selectin, and inducing production of ROS. Conventional therapies to reduce hyperglycemia, dyslipidemia and insulin resistance may effectively improve endothelial function and delay the onset of vascular complications. Novel therapeutic approaches designed to inhibit AGEs formation, reduce PKC activation, decrease inflammatory signals and restore the ox/redox balance of endothelium may be predicted to ameliorate vascular function in diabetic state. This review summarizes the current knowledge on the most important mechanisms involved in endothelial dysfunction during diabetes. In addition, novel therapeutic strategies that may result from recently identified targets are also described.

Overview

Integrity signals

Registry

Crossref · 10.2174/092986709787002853

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 280

Metadata

Authors
Potenza, M., Gagliardi, S., Nacci, C., Carratu, M., & Montagnani, M.
Affiliations
University of Bari Aldo Moro (IT)
Venue
Current Medicinal Chemistry
Published
2009-01-01
Volume
16
Issue
1
Pages
94-112
ISSN
0929-8673 (ISSN-L)
OpenAlex
W2116006961
Cited by
280
References
0
Citations by year
2026: 18 · 2025: 10 · 2024: 7 · 2023: 12 · 2022: 13 · 2021: 9 · 2020: 17 · 2019: 15 · 2018: 13 · 2017: 16 · 2016: 14 · 2015: 16 · 2014: 18 · 2013: 22 · 2012: 25
FWCI
12.22
Type
journal article
Language
en
Open access
closed
Locations
  • Current Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Keywords
endothelial dysfunction, diabetes mellitus, nitric oxide bioavailability, reactive oxygen species, oxidative stress, advanced glycation end products, protein kinase C, insulin resistance, hyperinsulinemia, dyslipidemia, endothelin-1, adhesion molecules, vascular inflammation, PI3-kinase, MAPK signaling, diabetic vascular complications, therapeutic target
MeSH terms
Animals, Hypolipidemic Agents, Diabetic Angiopathies, Endothelium, Vascular, Humans, Hypoglycemic Agents, Insulin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endothelial Dysfunction in Diabetes: From Mechanisms to Therapeutic Targets. https://app.cochat.ai/papers/10.2174/092986709787002853
The paper
Potenza, M., Gagliardi, S., Nacci, C., Carratu, M., & Montagnani, M. (2009). Endothelial Dysfunction in Diabetes: From Mechanisms to Therapeutic Targets. Current Medicinal Chemistry. https://doi.org/10.2174/092986709787002853

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.